All assets associated with the tag: Seqirus
Seqirus, a global vaccine maker with a newly expanded manufacturing plant in Holly Springs, has signed a $30.1 million federal contract to produce a potential vaccine against avian flu.
Seqirus Holly Springs held a ribbon cutting Monday morning to celebrate its expansion and new recognition for pandemic vaccine production and distribution.
Seqirus Holly Springs held a ribbon cutting Monday morning to celebrate its expansion and new recognition for pandemic vaccine production […]
Seqirus, which is expanding its Holly Springs facility, extended a partnership with BARDA to provide vaccinations against influenza strains, now and in future.
The flu vaccine that is made for all 4 strains is now approved for children as young at 6 months.
A new flu shot is FDA approved for kids as young as 6 months old.
Keely Arthur, WRAL reporter
A new flu shot is FDA approved for kids as young as 6 months old. You might not know that the shot will be made in Wake County.
Chris Lovingood, WRAL anchor/reporter
Flu vaccine producer Seqirus will work with the U.S. government to develop two vaccine candidates to combat future pandemics. Here's a detailed look at what's happening.
Seqirus will develop two vaccines against the seasonal flu from its Holly Springs manufacturing facility, and has won a multi-year federal contract for $34.95 million to do so.
RESEARCH TRIANGLE PARK – Seqirus hopes to raise the bar on flu prevention with the accelerated development of its next-generation influenza […]
With most of the world currently focused on the rapid spread of the Delta variant of COVID-19, we shouldn’t forget that flu season also is just around the corner.
Although most of us currently are consumed by the COVID-19 coronavirus, it’s also the season to be thinking about the flu. Seqirus isn't and touts its vaccine data.
While the world’s leading infectious disease experts consider whether the coronavirus that originated in Wuhan, China, could become the next pandemic, a Holly Springs company is working on a vaccine to protect humans from another deadly virus.